Molecular Crosstalk between the Immunological Mechanism of the Tumor Microenvironment and Epithelial–Mesenchymal Transition in Oral Cancer
暂无分享,去创建一个
Gnanasambandan Ramanathan | Kaviyarasi Renu | Sabariswaran Kandasamy | B. Vellingiri | Anirban Goutam Mukherjee | Uddesh Ramesh Wanjari | V. Veeraraghavan | Raja Ganesan | Alex George | Sathishkumar Vinayagam | A. Dey | D. S. Prabakaran | G. Doss C | A. V. Gopalakrishnan | A. Gopalakrishnan
[1] Haidong Fan,et al. TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway , 2022, Disease markers.
[2] J. W. Chadwick,et al. TNFα Signaling Is Increased in Progressing Oral Potentially Malignant Disorders and Regulates Malignant Transformation in an Oral Carcinogenesis Model , 2021, Frontiers in Oncology.
[3] R. Bologna-Molina,et al. Expression of Interleukin-1ß and Interleukin-8 in Oral Potentially Malignant Disorders and Carcinomas , 2021, Frontiers in Oral Health.
[4] I. Chattopadhyay,et al. Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer , 2021, Mediators of inflammation.
[5] A. Mackiewicz,et al. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance , 2021, Frontiers in Immunology.
[6] B. Cheng,et al. Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities , 2020, International journal of cancer.
[7] R. de Bree,et al. Staging and grading of oral squamous cell carcinoma: An update. , 2020, Oral oncology.
[8] J. Selvaraj,et al. Epithelial–mesenchymal transition in oral squamous cell carcinoma: An insight into molecular mechanisms and clinical implications , 2020, Journal of oral and maxillofacial pathology : JOMFP.
[9] H. Kumamoto,et al. Immunohistochemical assessment of Eph/ephrin expression in oral squamous cell carcinoma and precursor lesions , 2019, Odontology.
[10] Pu Zhang,et al. MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial-mesenchymal transition via the hedgehog signaling pathway. , 2019, Experimental cell research.
[11] Shanchun Guo,et al. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy. , 2019, Current medicinal chemistry.
[12] Xiaobing Chen,et al. CCL2 promotes cell migration by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma. , 2019, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[13] A. Abdollahi,et al. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue , 2019, Asian Pacific journal of cancer prevention : APJCP.
[14] K. Miyazawa,et al. Addiction of mesenchymal phenotypes on the FGF/FGFR axis in oral squamous cell carcinoma cells , 2019, bioRxiv.
[15] W. González-Arriagada,et al. Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and CXCR4 in squamous cell carcinoma of tongue and floor of the mouth , 2019, Medicina oral, patologia oral y cirugia bucal.
[16] Xiao-Wei Zhao,et al. The role of MAPK signaling pathway in formation of EMT in oral squamous carcinoma cells induced by TNF-α , 2019, Molecular Biology Reports.
[17] M. Masařík,et al. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review , 2019, Molecular Cancer.
[18] C. Blanpain,et al. EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.
[19] A. Breeze,et al. Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting , 2018, Biochemical Society transactions.
[20] D. Costea,et al. Aberrant expression of vimentin predisposes oral premalignant lesion derived cells towards transformation. , 2018, Experimental and molecular pathology.
[21] S. Rubtsova,et al. Role of Epithelial-Mesenchymal Transition in Tumor Progression , 2018, Biochemistry (Moscow).
[22] D. Antonini,et al. Functional and Mechanistic Insights into the Pathogenesis of P63-Associated Disorders. , 2018, The journal of investigative dermatology. Symposium proceedings.
[23] C. Soares,et al. FGF‐2 and FGFR‐1 might be independent prognostic factors in oral tongue squamous cell carcinoma , 2018, Histopathology.
[24] A. Burgess,et al. Epidermal growth factor receptor: Structure‐function informing the design of anticancer therapeutics , 2018, Experimental cell research.
[25] J. Murakami,et al. Anti-EGFR antibody cetuximab is secreted by oral squamous cell carcinoma and alters EGF-driven mesenchymal transition. , 2018, Biochemical and biophysical research communications.
[26] K. Miyazono,et al. Intracellular and extracellular TGF-β signaling in cancer: some recent topics , 2018, Frontiers of Medicine.
[27] Jianping Zhang,et al. Notch signalling induces epithelial‑mesenchymal transition to promote metastasis in oral squamous cell carcinoma. , 2018, International journal of molecular medicine.
[28] R. Weinberg,et al. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities , 2018, Frontiers of Medicine.
[29] M. Jolehar,et al. Prognostic New Marker (Bone Morphogenetic Protein 7) in Squamous Cell Carcinoma. , 2018, The journal of contemporary dental practice.
[30] Z. Akram,et al. S100 proteins in oral squamous cell carcinoma. , 2018, Clinica chimica acta; international journal of clinical chemistry.
[31] Balakrishnan,et al. Canonical Wnt pathway gene expression and their clinical correlation in oral squamous cell carcinoma , 2018, Indian journal of dental research : official publication of Indian Society for Dental Research.
[32] R. Kandpal,et al. Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers , 2018, BioMed research international.
[33] John Kuriyan,et al. Deep mutational analysis reveals functional trade-offs in the sequences of EGFR autophosphorylation sites , 2018, Proceedings of the National Academy of Sciences.
[34] D. Moslemi,et al. Immunohistochemical expression of TWIST in oral squamous cell carcinoma and its correlation with clinicopathologic factors , 2018, Journal of cancer research and therapeutics.
[35] M. Dong,et al. Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway , 2017, Cell Death and Disease.
[36] K. Anvari,et al. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters. , 2017, Archives of oral biology.
[37] R. Sader,et al. Tumor-associated Macrophages, Angiogenesis, and Tumor Cell Migration in Oral Squamous Cell Carcinoma , 2017, Annals of African medicine.
[38] B. Manjunatha,et al. Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia , 2017, Journal of the Korean Association of Oral and Maxillofacial Surgeons.
[39] A. Shavandi,et al. Keratin: dissolution, extraction and biomedical application. , 2017, Biomaterials science.
[40] G. Sauter,et al. High‐level &bgr;III‐tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome , 2017, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[41] G. Berx,et al. EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET. , 2017, Biochimica et biophysica acta. Reviews on cancer.
[42] T. Salo,et al. Histamine H4 receptor signalling in tongue cancer and its potential role in oral carcinogenesis - a short report , 2017, Cellular Oncology.
[43] Dongxi Xiang,et al. Wnt Signaling in Oral Cancer Initiating Cells , 2017 .
[44] Zhengmao Li,et al. TNF-α inhibits the migration of oral squamous cancer cells mediated by miR-765-EMP3-p66Shc axis. , 2017, Cellular signalling.
[45] Brendan J. McConkey,et al. The GRHL2/ZEB Feedback Loop—A Key Axis in the Regulation of EMT in Breast Cancer , 2017, Journal of cellular biochemistry.
[46] K. Cherubini,et al. Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge , 2017, Diagnostic Pathology.
[47] Takaaki Ito,et al. Notch1 in oral squamous cell carcinoma. , 2017, Histology and histopathology.
[48] D. Birnbaum,et al. De-repression of the RAC activator ELMO1 in cancer stem cells drives progression of TGFβ-deficient squamous cell carcinoma from transition zones , 2017, eLife.
[49] Qiang Zhang,et al. Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma , 2017 .
[50] T. Shibata,et al. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression , 2016, Oncology reports.
[51] K. Sakamoto. Notch signaling in oral squamous neoplasia , 2016, Pathology international.
[52] T. Dineshkumar,et al. Salivary and Serum Interleukin-6 Levels in Oral Premalignant Disorders and Squamous Cell Carcinoma: Diagnostic Value and Clinicopathologic Correlations , 2016, Asian Pacific journal of cancer prevention : APJCP.
[53] J. Ernst,et al. Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue , 2016, Oncotarget.
[54] S. Guelcher,et al. Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma , 2016, Oncotarget.
[55] M. Nie,et al. [Expression of cytokeratin 19 in the development and progression of oral squamous cell carcinoma]. , 2016, Shanghai kou qiang yi xue = Shanghai journal of stomatology.
[56] Longlong Wang,et al. Targeted silencing of CXCR4 inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma. , 2016, Oncology letters.
[57] A. Bhatt,et al. Role of interleukin-6 in cancer progression and therapeutic resistance , 2016, Tumor Biology.
[58] Jie Cheng,et al. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma , 2016, Oncotarget.
[59] B. Seliger,et al. Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma , 2016, Journal of Translational Medicine.
[60] Ming Tan,et al. GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification , 2016, Scientific Reports.
[61] R. Muschel,et al. Targeting the CCL2-CCR2 signaling axis in cancer metastasis , 2016, Oncotarget.
[62] Stephen T. C. Wong,et al. EMT is not required for lung metastasis but contributes to chemoresistance , 2015, Nature.
[63] Hao Sun,et al. [Expression of Twist and relation with epithelial-mesenchymal transition in oral squamous cell carcinoma]. , 2015, Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology.
[64] C. Obayashi,et al. Multivariate analyses of Ki-67, cytokeratin 13 and cytokeratin 17 in diagnosis and prognosis of oral precancerous lesions. , 2015, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[65] Yan Liu,et al. Over-expression of TWIST, an epithelial-mesenchymal transition inducer, predicts poor survival in patients with oral carcinoma. , 2015, International journal of clinical and experimental medicine.
[66] Qing Xu,et al. Expression of E-cadherin and vimentin in oral squamous cell carcinoma. , 2015, International journal of clinical and experimental pathology.
[67] T. Okamoto,et al. Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via MEK/ERK signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen. , 2014, International journal of oncology.
[68] D. Medici,et al. Signaling mechanisms of the epithelial-mesenchymal transition , 2014, Science Signaling.
[69] Yunong Wu,et al. Neuropilin-1 Promotes Epithelial-to-Mesenchymal Transition by Stimulating Nuclear Factor-Kappa B and Is Associated with Poor Prognosis in Human Oral Squamous Cell Carcinoma , 2014, PloS one.
[70] N. Dey,et al. Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas. , 2014, Oral diseases.
[71] Shaohui Huang,et al. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial–mesenchymal transition (EMT) in SCC15 cells , 2014, Tumor Biology.
[72] Amy Y. Chen,et al. Acetylated Tubulin (AT) as a Prognostic Marker in Squamous Cell Carcinoma of the Head and Neck , 2014, Head and Neck Pathology.
[73] Hau-Ren Chen,et al. Monocyte Chemotactic Protein 1 (MCP-1) Modulates Pro-Survival Signaling to Promote Progression of Head and Neck Squamous Cell Carcinoma , 2014, PloS one.
[74] N. Brockton,et al. Head and neck cancer: from anatomy to biology , 2013, International journal of cancer.
[75] B. Zhou,et al. The Role of Snail in EMT and Tumorigenesis. , 2013, Current cancer drug targets.
[76] E. Nkenke,et al. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia. , 2013, Oncology reports.
[77] M. Grimm,et al. Prognostic value of histamine H1 receptor expression in oral squamous cell carcinoma , 2013, Clinical Oral Investigations.
[78] H. Taubert,et al. Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients , 2012, Oral and Maxillofacial Surgery.
[79] B. Shalmon,et al. Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma. , 2011, Oral oncology.
[80] Hongmei Zhou,et al. Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts , 2011, BMC Cancer.
[81] S. Mocellin,et al. The dual role of tumor necrosis factor (TNF) in cancer biology. , 2010, Current Medicinal Chemistry.
[82] P. Lequerica-Fernández,et al. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis. , 2007, Journal of Oral Pathology & Medicine.
[83] C. Sotiriou,et al. Molecular markers of head and neck squamous cell carcinoma: Promising signs in need of prospective evaluation , 2006, Head & neck.
[84] J. Kim,et al. Prognostic value of activated Akt expression in oral squamous cell carcinoma , 2005, Journal of Clinical Pathology.
[85] E. Porfiri,et al. Beta-catenin gene analysis in oral squamous cell carcinoma. , 2005, International journal of immunopathology and pharmacology.
[86] D. Odde,et al. Modeling Cell Migration Mechanics. , 2018, Advances in experimental medicine and biology.
[87] Gang Chen,et al. Sonic Hedgehog Signalling Activation Contributes to ALCAM Over-Expression and Poor Clinical Outcome in Patients with Oral Squamous Cell Carcinoma. , 2018, The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association.
[88] Xiao‐Jing Wang,et al. Paradoxical roles of TGF-&bgr; signaling in suppressing and promoting squamous cell carcinoma , 2018, Acta biochimica et biophysica Sinica.
[89] N. Cirillo,et al. Cancer-associated fibroblasts regulate keratinocyte cell–cell adhesion via TGF-&bgr;-dependent pathways in genotype-specific oral cancer , 2017, Carcinogenesis.
[90] Bi-Jun Huang,et al. IL-8 suppresses E-cadherin expression in nasopharyngeal carcinoma cells by enhancing E-cadherin promoter DNA methylation. , 2016, International journal of oncology.
[91] Juri Kwak,et al. Hepatitis B virus X protein induces epithelial-mesenchymal transition by repressing E-cadherin expression via upregulation of E12/E47. , 2016, The Journal of general virology.
[92] J. Yook,et al. Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells. , 2016, Oncology reports.
[93] Yoichi Tanaka,et al. Cytokeratin 13, Cytokeratin 17, Ki-67 and p53 Expression in Upper Layers of Epithelial Dysplasia Surrounding Tongue Squamous Cell Carcinoma. , 2015, The Bulletin of Tokyo Dental College.
[94] Seiji Nakamura,et al. Possible involvement of ΔNp63 downregulation in the invasion and metastasis of oral squamous cell carcinoma via induction of a mesenchymal phenotype , 2013, Clinical & Experimental Metastasis.